Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Colorectal Dis ; 23(11): 2879-2893, 2021 11.
Artigo em Inglês | MEDLINE | ID: mdl-34473913

RESUMO

AIM: Minimal residual disease (MRD) is the net result of the biological properties of disseminated tumour cells and the effect of the immune system and treatment to eliminate them. The aim of this work is to report the changes in MRD status and immune function (lymphocyte count) after FOLFOX chemotherapy, and the outcome in Stage III colon cancer patients. METHOD: This study is a prospective, single-centre observational study. Lymphocyte counts were determined prior to and 1, 2 and 3 months after the completion of chemotherapy. Circulating tumour cells (CTCs) and bone marrow micrometastases were determined using immunocytochemistry with anticarcinoembryonic antigen prior to and 1 month after chemotherapy. MRD was classified as negative (Group I), micrometastasis positive only (Group II) and CTC positive (Group III). Changes in lymphocyte counts and MRD subtype following chemotherapy and relapse-free progression were analysed. RESULTS: Of the total of 185 patients, 83 (44.9%) relapsed. The risk of relapse significantly increased from Groups I to III (p < 0.001) and with decreasing lymphocyte count (p < 0.01). The lymphocyte count significantly decreased from Groups I to III (p < 0.001). Multivariance Cox regression analysis showed hazard ratios of 3.58 (Group II), 17.43 (Group III) and 0.39 (lymphocyte count) in predicting relapse. Following chemotherapy, improved lymphocyte count was associated with improved MRD subtype (p < 0.0001). Neither baseline lymphocyte count nor MRD subtype predicted response to chemotherapy. Five-year relapse-free survival for combined lymphocyte-MRD subtypes was 95%, 57% and 5% for Groups I to III, respectively (p < 0.001). CONCLUSION: Following chemotherapy, improvements in immune function were associated with improved MRD subtype and a better relapse-free survival.


Assuntos
Neoplasias do Colo , Recidiva Local de Neoplasia , Neoplasias do Colo/tratamento farmacológico , Intervalo Livre de Doença , Humanos , Neoplasia Residual , Prognóstico , Estudos Prospectivos , Resultado do Tratamento
2.
Langmuir ; 23(10): 5286-8, 2007 May 08.
Artigo em Inglês | MEDLINE | ID: mdl-17402766

RESUMO

Many phenomena take place during different types of emulsion inversions, particularly a change in interface curvature and drop size, which could be detected by backward light scattering. Monitoring the backscattering signal allows us to detect the emulsion inversion in three main cases, one transitional and two catastrophic types. The backscattering data could give some clue as to emulsion morphology, which is not available from conductivity measurements.

3.
Langmuir ; 21(15): 6712-6, 2005 Jul 19.
Artigo em Inglês | MEDLINE | ID: mdl-16008379

RESUMO

Commercial ethoxylated nonionic surfactant mixtures containing alcohol cosurfactant exhibit a three-phase behavior whose formulation strongly varies with the water/oil ratio. As a consequence, a change in water/oil ratio can result in a sequence of up to three different emulsion inversion processes, through a combination of formulation and composition effects.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...